Cynthia Schwalm Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cynthia Schwalm.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cynthia Schwalm. Cynthia Schwalm is Director in CALADRIUS BIOSCIENCES, INC. ($NBS) and in Kadmon Holdings, Inc. ($KDMN) and in G1 Therapeutics, Inc. ($GTHX) and Director in G1 Therapeutics, Inc. ($GTHX).
Latest Insider Trading Transactions of Cynthia Schwalm
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NBS, GTHX, KDMN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 3.58 | 96,975 | 347,171 | 96,975 | ||
| Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 0.00 | 37,735 | 0 | 80,417 | 42.7 K to 80.4 K (+88.41 %) |
| Jun 12 2020 | GTHX | G1 Therapeutics, I ... | Schwalm Cynthia | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
| May 14 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 4.44 | 85,034 | 377,551 | 85,034 | ||
| Mar 12 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Buy | P | 3.24 | 21,693 | 70,285 | 31,000 | 9.3 K to 31 K (+233.08 %) | |
| Mar 12 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Buy | P | 3.24 | 9,307 | 30,108 | 9,307 | 0 to 9.3 K | |
| Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 3.28 | 18,292 | 59,998 | 42,682 | 24.4 K to 42.7 K (+75.00 %) |
| Jun 14 2019 | GTHX | G1 Therapeutics, I ... | Schwalm Cynthia | Director | Option Exercise | A | 18.47 | 20,000 | 369,400 | 20,000 | |
| May 16 2019 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 2.29 | 100,000 | 229,000 | 164,935 | ||
| May 16 2019 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 2.29 | 100,000 | 229,000 | 164,935 | ||
| Jan 23 2019 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 2.27 | 64,935 | 147,402 | 64,935 | ||
| Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 4.95 | 12,121 | 59,999 | 24,390 | 12.3 K to 24.4 K (+98.79 %) |
| Dec 27 2018 | GTHX | G1 Therapeutics, I ... | Schwalm Cynthia | Buy | P | 18.45 | 1,420 | 26,196 | 1,500 | 80 to 1.5 K (+1,775.00 %) | |
| Jun 11 2018 | GTHX | G1 Therapeutics, I ... | Schwalm Cynthia | Director | Option Exercise | A | 38.39 | 20,000 | 767,800 | 20,000 |
Page: 1